Use of solriamfetol for the treatment of orphan diseases

EP4766353A1Pending Publication Date: 2026-07-01AXSOME THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
AXSOME THERAPEUTICS INC
Filing Date
2024-08-21
Publication Date
2026-07-01

Smart Images

  • Figure IMGF000004_0001
    Figure IMGF000004_0001
  • Figure IMGF000004_0002
    Figure IMGF000004_0002
  • Figure IMGF000047_0001
    Figure IMGF000047_0001
Patent Text Reader

Abstract

The present invention relates to a method of treating an orphan disease in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds, particularly solriamfetol and even more particularly solriamfetol hydrochloride.
Need to check novelty before this filing date? Find Prior Art